We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.61B
AUM Growth
+$447M
Cap. Flow
+$533M
Cap. Flow %
33.15%
Top 10 Hldgs %
11.86%
Holding
2,259
New
642
Increased
549
Reduced
466
Closed
595

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$4.13M
2
NVDA icon
NVIDIA
NVDA
+$4.12M
3
PFE icon
Pfizer
PFE
+$4.01M
4
LNG icon
Cheniere Energy
LNG
+$3.83M
5
HOLX
Hologic
HOLX
+$3.1M

Sector Composition

Rank Sector Weight
1 Financials 13.44%
2 Technology 13.16%
3 Healthcare 12.56%
4 Industrials 12.44%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QRVO icon
276
Qorvo
QRVO
$7.63B
$1.52M 0.09%
19,609
+17,104
+683% +$1.38M
JOE icon
277
St. Joe Company
JOE
$3.57B
$1.51M 0.09%
+24,095
New +$1.61M
SAH icon
278
Sonic Automotive
SAH
$3.15B
$1.51M 0.09%
22,055
+11,036
+100% +$689K
CABA icon
279
Cabaletta Bio
CABA
$439M
$1.51M 0.09%
561,726
+257,734
+85% +$716K
AGX icon
280
Argan
AGX
$7.98B
$1.5M 0.09%
2,760
+1,513
+121% +$617K
INFU icon
281
InfuSystem Holdings
INFU
$184M
$1.5M 0.09%
162,670
+34,839
+27% +$304K
CLDT
282
Chatham Lodging
CLDT
$630M
$1.5M 0.09%
190,593
+17,213
+10% +$128K
IDA icon
283
Idacorp
IDA
$8.23B
$1.5M 0.09%
10,479
+6,557
+167% +$899K
MLTX icon
284
MoonLake Immunotherapeutics
MLTX
$1.59B
$1.5M 0.09%
80,233
-9,003
-10% -$149K
TOST icon
285
Toast
TOST
$16.8B
$1.49M 0.09%
56,314
-3,945
-7% -$118K
EXEL icon
286
Exelixis
EXEL
$13.9B
$1.49M 0.09%
+34,776
New +$1.5M
AEE icon
287
Ameren
AEE
$31.5B
$1.49M 0.09%
+13,549
New +$1.45M
MRNA icon
288
Moderna
MRNA
$21.5B
$1.49M 0.09%
29,238
+3,664
+14% +$171K
EGBN icon
289
Eagle Bancorp
EGBN
$867M
$1.48M 0.09%
+59,663
New +$1.49M
DUOL icon
290
Duolingo
DUOL
$5.7B
$1.48M 0.09%
14,972
+9,040
+152% +$1.11M
ALGM icon
291
Allegro MicroSystems
ALGM
$8.58B
$1.48M 0.09%
+46,767
New +$1.61M
SITC icon
292
SITE Centers
SITC
$230M
$1.47M 0.09%
273,033
+203,671
+294% +$1.25M
WT icon
293
WisdomTree
WT
$2.97B
$1.47M 0.09%
101,227
+87,569
+641% +$1.35M
JXN icon
294
Jackson Financial
JXN
$8.32B
$1.47M 0.09%
13,875
-14,414
-51% -$1.61M
FBIN icon
295
Fortune Brands Innovations
FBIN
$6.12B
$1.47M 0.09%
37,622
+32,192
+593% +$1.67M
COKE icon
296
Coca-Cola Consolidated
COKE
$12.3B
$1.46M 0.09%
+7,637
New +$1.34M
ZNTL icon
297
Zentalis Pharmaceuticals
ZNTL
$308M
$1.45M 0.09%
620,407
-549,166
-47% -$1.42M
LXRX icon
298
Lexicon Pharmaceuticals
LXRX
$1.02B
$1.45M 0.09%
930,089
-66,146
-7% -$96.2K
NRP icon
299
Natural Resource Partners
NRP
$1.3B
$1.45M 0.09%
11,961
+4,442
+59% +$527K
EVLV icon
300
Evolv Technologies
EVLV
$943M
$1.45M 0.09%
238,763
+206,998
+652% +$1.21M

Similar funds

GSA Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, GSA Capital Partners held 2,259 positions worth $1.61B, up 39% from $1.16B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners deployed $533M of net new capital in Q1 2026, opening 642 new positions and adding to 549 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q1 2026 buy was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
  • GSA Capital Partners added most to Vanguard Short-Term Corporate Bond ETF in Q1 2026, an estimated $39.8M increase.
  • GSA Capital Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited EOG Resources in Q1 2026, selling an estimated $4.13M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.61B portfolio in Q1 2026.
  • GSA Capital Partners opened 642 new positions and closed 595 in Q1 2026.
  • GSA Capital Partners's portfolio value rose 39% quarter-over-quarter to $1.61B.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.